- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 501/00 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporinsSuch ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Patent holdings for IPC class C07D 501/00
Total number of patents in this class: 28
10-year publication summary
|
6
|
2
|
0
|
1
|
1
|
2
|
2
|
0
|
0
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| DSM Sinochem Pharmaceuticals Netherlands B.V. | 60 |
3 |
| Merck Sharp & Dohme LLC | 3748 |
2 |
| The Regents of the University of California | 19918 |
1 |
| Honeywell International Inc. | 13545 |
1 |
| Syngenta Crop Protection AG | 6054 |
1 |
| DSM IP Assets B.V. | 5591 |
1 |
| Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e.V. | 4948 |
1 |
| Basilea Pharmaceutica AG | 69 |
1 |
| Biotix, Inc. | 181 |
1 |
| Enanta Pharmaceuticals, Inc. | 428 |
1 |
| Lupin Limited | 434 |
1 |
| Meharry Medical College | 61 |
1 |
| Nanyang Technological University | 2006 |
1 |
| Shanghai Promoton Biotechnology Co., Ltd. | 1 |
1 |
| Sun Pharmaceutical Industries Limited | 748 |
1 |
| Teva Pharmaceutical Industries Ltd. | 789 |
1 |
| Teva Pharmaceuticals USA, Inc. | 894 |
1 |
| Theravance Biopharma Antibiotics IP, LLC | 6 |
1 |
| Trustees of Dartmouth College | 1085 |
1 |
| Universita' di Pisa | 106 |
1 |
| Other owners | 5 |